Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : RNAi -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (85)	9/10/2003 11:24:23 AM
From: bob zagorin	Read Replies (2) \| Respond to of 671

RNAi News: Innovative Newsletter to Focus on RNA Interference, New Tool For Functional Genomics and Drug Discovery NEW YORK, Sept. 10 /PRNewswire/ -- A weekly newsletter covering an important new life sciences research technology published its first issue this week. RNAi News is the first publication to focus on the field of RNA interference, a pioneering tool for studying gene function and developing new drugs. RNAi News is the latest application-focus newsletter from GenomeWeb LLC, a New York-based information provider serving the life science research community. Charter subscribers to the new publication include major biomedical research institutions, biotechnology companies, suppliers of RNAi tools and systems, and investment firms that follow the industry. The debut issue of RNAi News is available for free download at rnainews.com. RNAi News is edited by Doug Macron, a veteran biotechnology journalist who recently joined GenomeWeb from Reuters Health. Contact him at mail to: dmacron@genomeweb.com About GenomeWeb LLC GenomeWeb is a leading provider of news and information to scientists and technologists pursuing advanced research in genomics, proteomics, bioinformatics and drug discovery. In addition to RNAi News, it publishes the weekly application-focus newsletters ProteoMonitor, BioArray News, BioInform, and SNPtech Reporter. GenomeWeb also publishes the monthly magazine Genome Technology -- which published its own groundbreaking four-part series on RNA interference this summer -- and GenomeWeb Daily News, providing continuous technology and research news throughout the business day. SOURCE GenomeWeb LLC CO: GenomeWeb LLC ST: New York SU: PDT Web site: genomeweb.com prnewswire.com 09/10/2003 11:04 EDT